Stay updated on Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.

Latest updates to the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page
- Check2 days agoChange DetectedThe record history now shows the study status updated to Completed and the recruitment status set to No longer looking for participants, indicating enrollment has ended.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, signaling a new site version is in use. This is a metadata update and does not modify the study data or visible record content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe revision history now shows a new version (v3.6.5) replacing the previous v3.6.4, indicating a site update. This is a metadata update and does not change the study details or user-facing content.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3 in the footer. This reflects a new software release/build reference for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check74 days agoChange DetectedThe history now indicates a new site revision: v3.6.3 replaces the previous v3.6.2. This reflects a routine site update rather than any change to the study information.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page footer now shows Revision: v3.6.2. This indicates a new build/version of the page rather than changes to the study record.SummaryDifference0.0%

Stay in the know with updates to Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.